<DOC>
	<DOCNO>NCT02656589</DOCNO>
	<brief_summary>This projective observational study plan enroll 300 advance breast cancer patient , prove Her-2 positive use fluorescence situ hybridization ( FISH ) / immunohistochemistry , 100 healthy donor control . Before treatment , plasma microRNA collect detected microRNA extraction kit quantitative polymerase chain reaction ( qPCR ) , respectively . After analyzed microRNA expression microRNA predictive model , previously report team , enrol patient classify `` probable sensitive group '' `` probable resistant group '' . Herceptin combine chemotherapy backbone salvage treatment use least 3 month ; change local mass metastasis lesion treatment document evaluate response . Based result , investigator aim construct mathematical predictive model analyze correlation baseline microRNA expression level prognosis patient . And diagnosis microRNA kit plan manufacture</brief_summary>
	<brief_title>microRNA Human Epidermal Growth Factor Receptor 2 （HER2）Positive Patient Treated With Herceptin</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Trastuzumab</mesh_term>
	<criteria>1 . The patient sign write informed consent 2. female patient ≥ 18yrs , 3 . HER2 positive : immunohistochemistry ( +++ ) FISH ( + ) 4. stage IV 5. patient history chemotherapy , hormone therapy , radiotherapy surgery diagnosis breast cancer 6. result patient ' blood test follow : WBC≥3.0×109/L ; Plt≥100×109/L ; AST/SGOT ALT/AGPT≤tripple normal upper limit ; Creatinine &lt; double normal upper limit 7 . ECOG score 0 1 . 8 . The patient able take oral pill 1 . The patient never expose herceptin . 2 . The patient suffer nonbreast malignancy last 5 year , except cervical carcinoma situ , radical basal cell carcinoma squamous cell carcinoma . 3 . The life expectancy le 3 month . 4 . Severe hepatic function disorder , Child Pugh grade C. 5 . Severe cardiac function disorder , cardiac function grade III ; 6 . Prolonged QT interval ; 7 . Arrhythmia take antiarrhythmia drug ; 8 . Pregnant breast feed female .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>herceptin</keyword>
	<keyword>microRNA</keyword>
</DOC>